MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase InhibitionGürkan Mollaoglu, Trudy G. Oliver, Matthew R. Guthrie et al.|Cancer Cell|2017Cited by 607
The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune MicroenvironmentGürkan Mollaoglu, Trudy G. Oliver, Alex Jones et al.|Immunity|2018Cited by 216
Ovarian cancer-derived IL-4 promotes immunotherapy resistanceGürkan Mollaoglu, Brian D. Brown, Alexander Tepper et al.|Cell|2024Cited by 99
Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor ImmunityAlfonso R. Sánchez-Paulete, Brian D. Brown, Adam Marks et al.|Cancer Immunology Research|2022Cited by 93
Family matters: How MYC family oncogenes impact small cell lung cancerJohannes Brägelmann, Martin L. Sos, Stefanie Böhm et al.|Cell Cycle|2017Cited by 89